Yungjin Pharm. Co., Ltd. (003520.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

61.9x

Market Cap

KRW 203.38B

MomentumView details →

1D Return

−0.98%

YTD Return

−44.20%

RSI (14)

38.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

61.9x

Market Cap

KRW 203.38B

RSI (14)

38.0

MomentumView details →

1D Return

−0.98%

YTD Return

−44.20%

ProfitabilityView details →

Gross Margin

28.97%

Net Margin

−2.47%

EBITDA Margin

1.77%

ROE (TTM)

−7.26%

ROA (TTM)

−2.75%

Asset Turnover

1.10x

GrowthView details →

Revenue YoY

+0.60%

EPS YoY

—

FCF YoY

−14.39%

Revenue CAGR 3Y

+5.20%

EPS CAGR 3Y

—

EBITDA YoY

−85.91%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.90x

Current Ratio

1.47x

Quick Ratio

0.64x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

253.00B

Net Income (TTM)

−6.26B

Op. CF (TTM)

−2.57B

Latest newsMore news →

No recent news for 003520.KS.

Similar companies

Hyundai Pharmaceutical Co., Ltd.004310.KS Boditech Med Inc.206640.KQ Whan In Pharm Co.,Ltd.016580.KS Hansoh Pharmaceutical Group Company Limited03692.HK REYON Pharmaceutical Co., Ltd.102460.KS Samjin Pharmaceuticals Co., Ltd.005500.KS Find similar companies →

Latest newsMore news →

No recent news for 003520.KS.